Focus Stocks
Forest Laboratories Formed a Tweezer Bottom
Published on Friday, 06 January 2012 04:36 Written by Danny Miller
New York, January 6th (TradersHuddle.com) - Shares of Forest Laboratories, Inc. (NYSE:FRX) ended the trading
session higher by $0.1 or 0.33% from its previous close. Forest Laboratories' price action developed what can be considered a reversal pattern in the form of a tweezer bottom, which is a
candlestick pattern that is usually formed at the end of a downtrend. The tweezer bottom is considered a reversal pattern, so traders will need to monitor the
the price action for confirmation.
Forest Laboratories, Inc. (NYSE:FRX) develops, manufactures, and sells branded and generic forms of ethical drug products. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses.
Traders looking for an entry in Forest Laboratories can use the tweezers as a good reference point to establish the long position, as the pattern provides defined risk by giving a good reference point for support.
Traders are always looking for tweezer bottoms as they give an entry with a small risk defined, they are a leading indicator that provides an alert for a trend reversal or stabilization. The tweezers imply that bears or sellers were not able to push the stock lower, therefore providing the opportunity to look for a bounce. Below an example of Tweezer Bottom reversal patterns:

Related Articles
- Forest and Almirall to Present Aclidinium Bromide Clinical Data at the American Thoracic Society (ATS) International Conference
- Forest Laboratories, Inc. to Present Cariprazine and Levomilnacipran Results from Phase 3 Trials at American Psychiatric Association (APA) Annual Meeting
- New Ratings ( FRX, NEPT, PDCO )
- Forest Laboratories, Inc. and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients with Major Depressive Disorder
- Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012
- Forest Laboratories, Inc. to Host Investor Meeting to Review Company’s Late-Stage Product Development Pipeline and Commercialization Strategy
- Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2012 Earnings Per Share of $0.72 Including $0.06 Per Share of Acquisition Amortization
- Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2012 Fourth Quarter Earnings
- Forest Laboratories, Inc. Announces Buyout of Bystolic Royalties from Janssen Pharmaceutica NV
- Forest Laboratories and Almirall Announce FDA has Extended the Review Period for Aclidinium Bromide
Related Partner Headlines
- Think Like the Father of Value Investing - TheStreet.com
- Notable Call Options Activity in Forest Laboratories - Benzinga
- Forest Laboratories and Pierre Fabre Medicament Announce Positive Phase III Results For Levomilnacipran in Patients with Major Depressive Disorder - Benzinga
- From Earlier: Forest Laboratories, Inc. and Gedeon Richter Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia - Benzinga
- From Earlier: Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler - Benzinga
- From Earlier: Forest and Almirall Announce Positive FDA Advisory Committee's Recommendation for Approval of Aclidinium Bromide for the Treatment of Chronic Obstructive Pulmonary Disease - Benzinga
- Analysts' Actions: GOOG, FRX, JBHT, KSU - TheStreet.com
- Forest Labs Posts Weak Quarter - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Ex-Dividend Stocks: Johnson & Johnson, McGraw-Hill - TheStreet.com -
'Massive Increase' in Bank M&A Coming: Hedge Fund Pro - TheStreet.com -
5 Things You Should Know Before the Stock Market Opens - TheStreet.com -
Beware the Three 'F's - TheStreet.com -
Spring Slide in Full Swing - TheStreet.com -
Stocks to Watch: Hewlett-Packard, Dell - TheStreet.com -
Advantest Corp Stock Upgraded (ATE) - TheStreet.com -
BCB Bancorp Inc. Stock Upgraded (BCBP) - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,502.81 Trade time:4:04PM EDT Value change:▼1.67 (-0.01%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,316.63 Trade time:4:32PM EDT Value change:▲0.64 (0.05%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.08 Trade time:5:16PM EDT Value change:▼8.13 (-0.29%)In The Wires
-
Innovative Composites International Inc. Announces Graduation from Tier 2 to Tier 1 of the TSX Venture Exchange -
Underground Energy reaches target depth on Chamberlin 3-2 well -
Explor Resources Inc. Joins OTCQX -
Ralcorp Acquires Private-Brand Cookie Maker, Petri Baking Products -
Monsanto Company to Purchase Planting Technology Developer Precision Planting, a Leader in Delivering Yield Through Technology -
Rentrak And MasterCard Collaborate To Bring Improved Media Planning And Buying Analytics To TV Advertisers -
Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting -
NCAA Division I track and field championship hopefuls from the Eastern U.S. to run qualifier on track of the Olympics









